These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2540705)

  • 1. Mycobacteria and the new quinolones.
    Leysen DC; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1989 Jan; 33(1):1-5. PubMed ID: 2540705
    [No Abstract]   [Full Text] [Related]  

  • 2. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
    Franzblau SG; Parrilla ML; Chan GP
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):66-9. PubMed ID: 8392100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
    McDermott-Lancaster RD; Banerjee DK
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA; Gomez Garcia AC
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanism of the acquisition of new-quinolone resistance in Mycobacterium leprae and M. tuberculosis and rapid differentiation methods for resistant bacilli].
    Kim H; Suzuki H; Matsuoka M; Matsuba T; Yokoyama K; Nakajima C; Suzuki Y
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):17-27. PubMed ID: 21404592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of compound TH 270 (N-p-isobutoxyphenyl-N'-p'- -pyridyl-ethyl-phenylthiourea) on the experimental infection with Mycobacterium lepraemurium and Mycobacterium leprae.
    Pattyn SR; Wagner WH
    Ann Soc Belg Med Trop; 1972; 52(1):55-61. PubMed ID: 4621868
    [No Abstract]   [Full Text] [Related]  

  • 8. The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
    Grosset JH; Baohong J; Ito T
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):807-13. PubMed ID: 3125288
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mystery of the mycobacterial 'persistor'.
    Grange JM
    Tuber Lung Dis; 1992 Oct; 73(5):249-51. PubMed ID: 1493231
    [No Abstract]   [Full Text] [Related]  

  • 11. [What Hansen's disease research learned from tuberculosis research: from molecular biological aspect].
    Suzuki Y; Yamaguchi T; Kim H; Yokoyama K; Nakajima C
    Nihon Hansenbyo Gakkai Zasshi; 2014 Dec; 83(3):21-7. PubMed ID: 25826852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifamycin resistance in mycobacteria.
    Cole ST
    Res Microbiol; 1996; 147(1-2):48-52. PubMed ID: 8761722
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on MOTT bacilli (Mycobacteria other than tubercle bacilli).
    Byrne J; Conalty ML
    J Ir Med Assoc; 1970 Mar; 63(393):91-8. PubMed ID: 4190045
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1995; 49 Suppl 2():67-75. PubMed ID: 8549419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problem of resistance in the treatment of Mycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy].
    Seydel JK; Schaper KJ
    Pharm Unserer Zeit; 1995 Nov; 24(6):313-23. PubMed ID: 8592712
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitazoxanide is active against Mycobacterium leprae.
    Bailey MA; Na H; Duthie MS; Gillis TP; Lahiri R; Parish T
    PLoS One; 2017; 12(8):e0184107. PubMed ID: 28850614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The susceptibility of Mycobacterium tuberculosis and atypical mycobacteria in northern Israel.
    Cahana Z; Gabbay R; Raz R
    Drugs; 1995; 49 Suppl 2():171-2. PubMed ID: 8549291
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ofloxacin in mycobacteriosis therapy].
    Padełskaya EN
    Antibiot Khimioter; 1997; 42(11):26-31. PubMed ID: 9463298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.